These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29188871)

  • 1. Impact of Age on the Association Between Body Mass Index and All-Cause Mortality in Patients with Atrial Fibrillation.
    Wu S; Yang YM; Zhu J; Wan HB; Wang J; Zhang H; Shao XH
    J Nutr Health Aging; 2017; 21(10):1125-1132. PubMed ID: 29188871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between body mass index and mortality in atrial fibrillation patients with and without diabetes mellitus: Insights from a multicenter registry study in China.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2242-2251. PubMed ID: 32900569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-specific association between body mass index and all-cause mortality in patients with atrial fibrillation.
    Lyu SQ; Yang YM; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Ren JM
    Clin Cardiol; 2020 Jul; 43(7):706-714. PubMed ID: 32352584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Body Mass Index on the Prognosis of Japanese Patients With Non-Valvular Atrial Fibrillation.
    Inoue H; Kodani E; Atarashi H; Okumura K; Yamashita T; Origasa H;
    Am J Cardiol; 2016 Jul; 118(2):215-21. PubMed ID: 27255662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.
    Wang J; Yang YM; Zhu J; Zhang H; Shao XH; Tian L; Huang B; Yu LT; Gao X; Wang M
    Clin Res Cardiol; 2014 Jul; 103(7):533-42. PubMed ID: 24535378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study.
    Wang L; Du X; Dong JZ; Liu WN; Zhou YC; Li SN; Guo XY; Jiang CX; Yu RH; Sang CH; Tang RB; Long DY; Liu N; Bai R; Macle L; Ma CS
    Clin Res Cardiol; 2019 Dec; 108(12):1371-1380. PubMed ID: 30953181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overweight and obesity in patients with atrial fibrillation: Sex differences in 1-year outcomes in the EORP-AF General Pilot Registry.
    Boriani G; Laroche C; Diemberger I; Fantecchi E; Meeder J; Kurpesa M; Baluta MM; Proietti M; Tavazzi L; Maggioni AP; Lip GYH;
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):566-572. PubMed ID: 29345382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and the risk of all-cause mortality among patients with nonvalvular atrial fibrillation: a multicenter prospective observational study in China.
    Wan H; Wu S; Wang J; Yang Y; Zhu J; Shao X; Huang B; Zhang H
    Eur J Clin Nutr; 2017 Apr; 71(4):494-499. PubMed ID: 27782115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry.
    Bertomeu-Gonzalez V; Moreno-Arribas J; Esteve-Pastor MA; Roldán-Rabadán I; Muñiz J; Raña-Míguez P; Ruiz-Ortiz M; Cequier Á; Bertomeu-Martínez V; Badimón L; Anguita M; Lip GYH; Marín F;
    J Am Heart Assoc; 2020 Jan; 9(1):e013789. PubMed ID: 31870235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 'obesity paradox' in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial.
    Sandhu RK; Ezekowitz J; Andersson U; Alexander JH; Granger CB; Halvorsen S; Hanna M; Hijazi Z; Jansky P; Lopes RD; Wallentin L
    Eur Heart J; 2016 Oct; 37(38):2869-2878. PubMed ID: 27071819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience.
    Wang HJ; Si QJ; Shan ZL; Guo YT; Lin K; Zhao XN; Wang YT
    PLoS One; 2015; 10(4):e0123516. PubMed ID: 25848965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation.
    Murakawa Y; Ikeda T; Ogawa S; Kitazono T; Nakagawara J; Minematsu K; Miyamoto S; Hayashi Y; Kidani Y; Okayama Y; Sunaya T; Sato S; Yamanaka S
    Heart Vessels; 2020 Aug; 35(8):1125-1134. PubMed ID: 32253531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass index is associated with prognosis in Japanese elderly patients with atrial fibrillation: an observational study from the outpatient clinic.
    Yanagisawa S; Inden Y; Yoshida N; Kato H; Miyoshi-Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Hirai M; Murohara T
    Heart Vessels; 2016 Sep; 31(9):1553-61. PubMed ID: 26498940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
    Badheka AO; Rathod A; Kizilbash MA; Garg N; Mohamad T; Afonso L; Jacob S
    Am J Med; 2010 Jul; 123(7):646-51. PubMed ID: 20609687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and adverse events in patients with incident atrial fibrillation.
    Overvad TF; Rasmussen LH; Skjøth F; Overvad K; Lip GY; Larsen TB
    Am J Med; 2013 Jul; 126(7):640.e9-17. PubMed ID: 23601271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of body mass index on mortality and hospitalisation of patients with atrial fibrillation.
    Ball J; Løchen ML; Carrington MJ; Wiley JF; Stewart S
    Eur J Cardiovasc Nurs; 2018 Oct; 17(7):627-636. PubMed ID: 29664325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI differences among in-hospital management and outcomes in patients with atrial fibrillation: findings from the Care for Cardiovascular Disease project in China.
    Deng F; Zhang Y; Zhao Q; Deng Y; Gao S; Zhang L; Dong M; Yuan Z; Lei X;
    BMC Cardiovasc Disord; 2020 Jun; 20(1):270. PubMed ID: 32503432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Mass Index and Clinical Outcomes in Asian Patients With Atrial Fibrillation Receiving Oral Anticoagulation.
    Lee SR; Choi EK; Jung JH; Park SH; Han KD; Oh S; Lip GYH
    Stroke; 2021 Jan; 52(2):521-530. PubMed ID: 33423512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants.
    Park CS; Choi EK; Kim HM; Lee SR; Cha MJ; Oh S
    Heart Rhythm; 2017 Apr; 14(4):501-507. PubMed ID: 28042092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between triglyceride glucose-body mass index and all-cause mortality in critically ill patients with atrial fibrillation: a retrospective study from MIMIC-IV database.
    Hu Y; Zhao Y; Zhang J; Li C
    Cardiovasc Diabetol; 2024 Feb; 23(1):64. PubMed ID: 38341579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.